文献速递垂体与肾上腺疾病

原发性醛固酮增多症患者的诊疗路径:肾上腺静脉采样的效用与局限

Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

常见亚型为醛固酮瘤(APA)和双侧肾上腺增生(BHA),APA可手术治愈而BHA需盐皮质激素受体拮抗剂(MRA)治疗。本文以实用风格综述了在资源有限条件下如何评估患者是否需影像学和肾上腺静脉采样(AVS),并利用APA及手术获益预测因素限制部分患者的进一步检查。

要点

  • 高血压患者中PA患病率高于普遍认识,应重视筛查。
  • APA与BHA鉴别关键,APA可手术治愈,BHA需MRA治疗。
  • AVS有创昂贵,需根据获益可能性个体化选择。

核心结论

  • PA在高血压患者中患病率高于普遍预期,呈从轻度到重度的醛固酮过量谱系。
  • APA等单侧醛固酮分泌亚型可手术治愈,BHA应使用MRA药物治疗。
  • AVS发现APA并实现手术治愈时价值大,但BHA无论是否行AVS均用MRA治疗。

主要发现

  • PA最常见亚型为APA和BHA,二者治疗策略不同。
  • PA管理主要短板是筛查率低以及区分APA与BHA的影像和介入操作(尤其AVS)昂贵且技术挑战大。
  • 近十年关于APA及手术获益预测因素的信息爆炸有助于限制部分筛查阳性患者的进一步评估。

临床怎么用

  • 在筛查阳性后,应先评估患者从影像和AVS获益的可能性,再决定是否进行这些检查。
  • 若AVS识别APA且可手术治愈,则AVS价值大;BHA患者无论是否行AVS均采用MRA治疗。
  • 利用APA和手术获益的预测因素,可对部分患者限制进一步评估。

局限性

  • 即使最好的资源和设施也存在局限性,本文建议需 recognizing 这些限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Several studies over the past 3 decades document a higher prevalence of primary aldosteronism (PA) among hypertensive patients than generally presumed. PA exists as a spectrum from mild to severe aldosterone excess. Although a variety of PA subtypes exist, the 2 most common are aldosterone-producing adenomas (APAs) and bilateral hyperaldosteronism (BHA). The distinction is important, because APA-and other subtypes, with aldosterone production mostly from 1 adrenal-can be cured surgically, and BHA should be treated medically with mineralocorticoid-receptor antagonists (MRAs). The major shortcomings in the tailored management of patients with possible PA are the low rates of screening for case identification and the expensive and technically challenging imaging and interventional procedures required to distinguish APA from BHA, especially adrenal vein sampling (AVS). When AVS identifies an APA and allows the patient to be cured surgically, the procedure is of great value. In contrast, the patient with BHA is treated with MRA whether AVS is performed or not. Consequently, it is prudent to gauge how likely it is to benefit from imaging and AVS in each case prior to embarking on these studies. The explosion of information about PA in the past decade, including predictors of APA and of surgical benefit, are useful in limiting the evaluation for some patients with a positive PA screening test. This article will review our suggestions for approaching these patients in a pragmatic style, recognizing the limitations to even the best resources and facilities.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Turcu AF, Auchus R. Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling. J Clin Endocrinol Metab. 2021. PMID: 33382421. doi:10.1210/clinem/dgaa952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。